Aptevo Therapeutics Inc.APVONASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank25
5Y CAGR-66.9%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-66.9%/yr
Long-term compound
Percentile
P25
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$71000.00-79.8%
2024$352000.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$17.85M+698.7%
2019$2.23M-80.1%
2018$11.21M+123.8%
2017$5.01M-79.3%
2016$24.18M-